Compare BHC & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHC | ITGR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 3.0B |
| IPO Year | 1996 | 2000 |
| Metric | BHC | ITGR |
|---|---|---|
| Price | $4.97 | $82.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $8.33 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 2.5M | 847.9K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | N/A |
| EPS | 0.42 | ★ 2.89 |
| Revenue | ★ $8,724,000,000.00 | $1,853,637,000.00 |
| Revenue This Year | $4.48 | $1.69 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | ★ $12.02 | $28.84 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $4.28 | $62.00 |
| 52 Week High | $8.69 | $127.56 |
| Indicator | BHC | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 25.63 | 44.24 |
| Support Level | N/A | $82.78 |
| Resistance Level | $7.22 | $87.54 |
| Average True Range (ATR) | 0.20 | 2.73 |
| MACD | -0.07 | -0.43 |
| Stochastic Oscillator | 0.76 | 14.66 |
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.